Xiaoqinglong decoction mitigates nasal inflammation and modulates gut microbiota in allergic rhinitis mice
Authors:
Open Access
- 15 May 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 15, 1290985
Abstract
Introduction: Allergic rhinitis (AR) is a respiratory immune system disorder characterized by dysregulation of immune responses. Within the context of AR, gut microbiota and its metabolites have been identified as contributors to immune modulation. These microorganisms intricately connect the respiratory and gut immune systems, forming what is commonly referred to as the gut-lung axis. Xiaoqinglong Decoction (XQLD), a traditional Chinese herbal remedy, is widely utilized in traditional Chinese medicine for the clinical treatment of AR. In this study, it is hypothesized that the restoration of symbiotic microbiota balance within the gut-lung axis plays a pivotal role in supporting the superior long-term efficacy of XQLD in AR therapy. Therefore, the primary objective of this research is to investigate the impact of XQLD on the composition and functionality of the gut microbiota in a murine model of AR.Methods: An ovalbumin-sensitized mouse model to simulate AR was utilized, the improvement of AR symptoms after medication was investigated, and high-throughput sequencing was employed to analyze the gut microbiota composition.Results: XQLD exhibited substantial therapeutic effects in AR mice, notably characterized by a significant reduction in allergic inflammatory responses, considerable alleviation of nasal symptoms, and the restoration of normal nasal function. Additionally, following XQLD treatment, the disrupted gut microbiota in AR mice displayed a tendency toward restoration, showing significant differences compared to the Western medicine (loratadine) group.Discussion: This results revealed that XQLD may enhance AR allergic inflammatory responses through the regulation of intestinal microbiota dysbiosis in mice, thus influencing the dynamics of the gut-lung axis. The proposal of this mechanism provides a foundation for future research in this area.Keywords
This publication has 17 references indexed in Scilit:
- Eosinophilic allergic rhinitis is strongly associated with the CD45RBlo subset of CD161+ Th2 cells that secretes IL‐2, IL‐3, IL‐4, IL‐5, IL‐9, and IL‐13Allergy, 2023
- A Synopsis of Guidance for Allergic Rhinitis Diagnosis and Management From ICAR 2023The Journal of Allergy and Clinical Immunology: In Practice, 2023
- Gut microbiota: A new insight into lung diseasesBiomedicine & Pharmacotherapy, 2022
- Current Use of Probiotics and Prebiotics in AllergyThe Journal of Allergy and Clinical Immunology: In Practice, 2022
- Blocking histone deacetylase activity as a novel target for epithelial barrier defects in patients with allergic rhinitisJournal of Allergy and Clinical Immunology, 2019
- Analysis of Transcriptionally Active Bacteria Throughout the Gastrointestinal Tract of Healthy IndividualsGastroenterology, 2019
- A multicenter study on the efficacy and safety of So-Cheong-Ryong-Tang for perennial allergic rhinitisComplementary Therapies in Medicine, 2019
- A curious connection: Teasing apart the link between gut microbes and lung diseaseNature Medicine, 2017
- Host–microbiota interactions: epigenomic regulationCurrent Opinion in Immunology, 2017
- Probiotics and immunityJournal of Gastroenterology, 2009